HK1001822A1 - Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride - Google Patents

Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride

Info

Publication number
HK1001822A1
HK1001822A1 HK98100761A HK98100761A HK1001822A1 HK 1001822 A1 HK1001822 A1 HK 1001822A1 HK 98100761 A HK98100761 A HK 98100761A HK 98100761 A HK98100761 A HK 98100761A HK 1001822 A1 HK1001822 A1 HK 1001822A1
Authority
HK
Hong Kong
Prior art keywords
hypertension
once
diltiazem hydrochloride
day treatment
oral application
Prior art date
Application number
HK98100761A
Inventor
Rudolf Altevogt
Helmut Augart
Heinrich Bahrmann
Renata Bakovic-Alt
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6339959&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1001822(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of HK1001822A1 publication Critical patent/HK1001822A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Medicaments containing diltiazem hydrochloride in dosages of 90-270 mg with an in vitro rate of release of the active substance of 20 - 70% after 1 h, 35 - 85% after 2 h, 50 - 100% after 3.5 h and at least 60% after 5 h, are used for the treatment of hypertension by a single daily oral dose.
HK98100761A 1987-11-06 1998-02-02 Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride HK1001822A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873737741 DE3737741A1 (en) 1987-11-06 1987-11-06 ORAL MEDICAL FORM FOR THE ONLY DAILY TREATMENT OF HYPERTENSION WITH DILTIAZEMHYDROCHLORIDE

Publications (1)

Publication Number Publication Date
HK1001822A1 true HK1001822A1 (en) 1998-07-10

Family

ID=6339959

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98100761A HK1001822A1 (en) 1987-11-06 1998-02-02 Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride

Country Status (6)

Country Link
EP (1) EP0315197B1 (en)
AT (1) ATE85218T1 (en)
DE (2) DE3737741A1 (en)
ES (1) ES2053683T3 (en)
GR (1) GR3007110T3 (en)
HK (1) HK1001822A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3922167A1 (en) * 1988-04-16 1991-01-17 Sanol Arznei Schwarz Gmbh Oral diltiazem hydrochloride dosage forms - for admin. once a day, contg. fast- and delayed-release components
IL92484A0 (en) * 1988-11-30 1990-08-31 Schering Corp Sustained release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5834024A (en) 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3024416C2 (en) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Process for the production of medicaments with sustained release of active substances
DE3125178A1 (en) * 1981-06-26 1983-01-13 Gödecke AG, 1000 Berlin METHOD FOR THE TIMED CONTROL OF THE RELEASE OF ACTIVE SUBSTANCES FROM ACTIVE SUBSTANCE PREPARATIONS, IN PARTICULAR DRUG PREPARATIONS
JPS59231018A (en) * 1983-06-10 1984-12-25 Tanabe Seiyaku Co Ltd Cholesterol-lowering agent
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1188212B (en) * 1985-12-20 1988-01-07 Paolo Colombo SYSTEM FOR THE RELEASE SPEED OF ACTIVE SUBSTANCES
US4654372A (en) * 1986-01-10 1987-03-31 Warner-Lambert Company Method for using verapamil for treating stroke
IT1200217B (en) * 1986-09-30 1989-01-05 Valducci Roberto MEMBRANE FOR PHARMACEUTICAL AND INDUSTRIAL USE
DK173505B1 (en) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Process for producing a slow release diltiazem pellet and using pellets thus prepared

Also Published As

Publication number Publication date
EP0315197B1 (en) 1993-02-03
DE3737741A1 (en) 1989-05-18
ES2053683T3 (en) 1994-08-01
EP0315197A1 (en) 1989-05-10
GR3007110T3 (en) 1993-07-30
DE3878154D1 (en) 1993-03-18
ATE85218T1 (en) 1993-02-15

Similar Documents

Publication Publication Date Title
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
TW355683B (en) Composition containing micronized nebivolol
AU7792987A (en) Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof
AU6060896A (en) Oral 1alpha-hydroxyprevitamin D
AU2584192A (en) Bone-growth-stimulating composition
IL95691A0 (en) Thienylcarboxylates of amino alcohols,their preparation and pharmaceutical compositions containing them
ATE67677T1 (en) MEDICATIONS FOR ORAL ADMINISTRATION CONTAINING 10 TO 240 MG OF DIHYDROPYRIDINE IN A SINGLE DOSE.
GR1002564B (en) Oral solid pharmaceutical form and administration therefor
ZA883602B (en) Medicament
AU8199187A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
MY103741A (en) Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process
ZA905861B (en) Pharmaceutical composition for oral administration containing nac
IE940341L (en) Anti-atherosclerotic diaryl compound
AU555093B2 (en) Calcium-antagonist composition
HK134494A (en) Substituted release azelastine containing medicaments
AU1866888A (en) Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
HK1001822A1 (en) Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride
NZ229422A (en) Certain (2',5')-oligoadehylate derivatives and pharmaceutical use
LT97012A (en) Carbamazepine medicament with retarded active substance release
MX9800809A (en) Process for preparing solid dosage forms of very low-dose drugs.
GB9420748D0 (en) 1,5 benzodiazepine derivatives
GB8608893D0 (en) D-nor-7-ergoline derivatives
IL79207A0 (en) Pharmaceutical compositions containing terguide

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)